Lactobio has established and built a proprietary discovery and screening platform consisting of more than 1000 new Lactic Acid Bacteria (LAB) and the collection is continuously growing with new isolates. The LAB collection is screened to identify the best probiotic strains to target a specific need or microbiome dysfunctions associated with specific diseases.
Staphylococcus aureus & MRSA
Lactiplantibacillus plantarum LB244R® is a Gram positive lactic acid producing bacterium. It was specifically selected because of its ability to inhibit the growth of pathogenic Staphylococcus aureus including Methicillin Resistant Staphylococcus aureus (MRSA) and the CC1 pathogen.
Lactiplantibacillus plantarum LB356R® was specifically selected for its ability to co-aggregate with the pathogenic ribotypes of Cutibacterium acnes and thereby inhibit the growth of pathogenic Cutibacterium acnes and biofilm formation resulting in acnes vulgaris.